This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Other Posts Labrats, Patents, and Section 3(i): Madras High Court Grants Patent for Antibody Production in Genetically Modified Non-human Animals Recently, the Madras High Court delivered a noteworthy ruling in Kymab Limited v. GSK sues Moderna for infringing its COVID-19 vaccine patents. Bentley Systems Inc & Anr.
Case Summaries Gilead Sciences Inc vs Union Of India on 19 December, 2024 (Madras High Court) Image from here The writ petition pertains to a patentapplication filed by the petitioner, which was contested by the 4 th respondent through a post-grant opposition. Macleods Pharmaceuticals Ltd vs The Controller Of Patents & Anr.
Cloudbreak Therapeutics, LLC addresses whether an IPR petitioner can assert Article III standing on appeal based on potential infringement liability and potential preclusive effects on its patents. 10,149,820 (the “’820 patent”), which is directed to compositions and methods for treating pterygium. Background Cloudbreak owns U.S.
The USPTO is seeking comments on “the state of patent eligibility jurisprudence” and how eligibility law impacts both innovation and investment-in-innovation. and (2) Is patent eligibility a question of law for the court or a question of fact for the jury? The deadline for submissions is October 15, 2021. Berkheimer, No.
The consistent issues that the US cites for placing India in the Special 301 Report are inter alia, India’s provisions on revocation of patents, oppositions, lack against the presumption of validity, lack of data exclusivity provisions and Section 3(d). India and the US have been at loggerheads over patent issues until recently.
Comments Invited on AI Governance and Guidelines Development Report (February 27) The office of CGPDTM has invited comments on the Draft Guidelines for Processing PatentApplications of Ayush Systems and Related Inventions for providing clarity on the filing and processing of patentapplications of Ayush Systems and related inventions.
Comments Invited on AI Governance and Guidelines Development Report (February 27) The office of CGPDTM has invited comments on the Draft Guidelines for Processing PatentApplications of Ayush Systems and Related Inventions for providing clarity on the filing and processing of patentapplications of Ayush Systems and related inventions.
On April 20, 2023, the United States Patent and Trademark Office (USPTO) announced several proposed rule changes that would have an impact on patentapplicants, patent holders, and patent challengers. By: Proskauer - Minding Your Business
Micro Labs Limited the Delhi High Court granted an ex-parte interim injunction in favour of the plaintiff in a case involving a patent of the compound ‘Apixaban’. The Ministry of Commerce and Industry has announced an 80% reduction in patentapplication fees for all recognised educational institutions. and held that Google Inc.
settled three Inter Partes Review (IPR) proceedings concerning patents covering Alexion’s blockbuster humanized monoclonal antibody drug Soliris®, with Amgen obtaining a royalty-free license for marketing a biosimilar prior to expiration of the patents at issue. The patents at issue are U.S. Patent Nos.
Over to Konstantin for the story and his take on the developments: "Some may associate businesses whose primary aim is to assert patents in litigation to obtain license revenue with the Eastern District of Texas or the Unwired Planet decision in the UK, and not think about cases further afield from Marshall, Texas or London.
Assistant Controller: The Court Reminds the Patent Office to Give Reasons DHC recently remanded a patent rejection order to the IPO, which had rejected the application due to the applicant’s failure to submit a written statement on time. What does this reveal about the quality of patent grant/rejection orders?
Highlights of the week Jab We Met (if at all): Do Patent Oppositions and Examination Run on a Parallel track? Delhi High Court to Examine Do patent oppositions and examinations run on parallel tracks? Controller of Patents and Designs. India currently holds 127 patents for 6G,” says Telecom Minister Ashwini Vaishnaw.
Highlight of the Week Comments on the Draft Patent (Amendment) Rules, 2023 Image by rawpixel.com on Freepix Comments pertaining to transparency and on substantive proposals within the draft Patent (Amendment) Rules, 2023, submitted to the Ministry of Commerce. What’s the best way forward? under the Biological Diversity Act.
In this post, I will be analysing the recommendations pertaining to the amendment of patent laws in order to facilitate inventorship and ownership by AI. I will be restricting the discussion to the evaluation of the Indian patent regime, as the implications of AI on Indian copyright law has been previously dealt with here.
In G 1/22 (and G 2/22), the Enlarged Board of Appeal (EBA) found that there is a strong rebuttable presumption that an applicant of a European patentapplication is entitled to claim priority. The Broad Institute famously lost a highly commercially valuable CRISPR patent for invalid priority ( T 844/18 , IPKat ).
Cloudbreak Therapeutics, LLC , provides some interesting insights into patent challenge strategies, and their consequences, when a potentially infringing product is not yet on the market. Allgenesis lost at the Patent Trial and Appeal Board (PTAB), which issued a final written decision upholding the patentability of the challenged claims.
This liberty to benefit from one’s intellectual creation gives rise to a bundle of rights related to intellectual property, including, Patents, Copyrights, Trademarks, Geographical Indications, among others. Nevertheless, awareness about dispute settlement strategies can minimise the economic and legal costs of ignoring IPR law.
Delhi High Court however permitted the Defendant to file these documents holding them essential to indicate Defendant’s assertion that the suit design lacks novelty, which it held to be one of the defences available in a patent infringement action. Delhi High Court decreed the suit as per the terms settlement between the parties.
Here is our recap of last week’s top IP developments including summary of the posts on the DHC’s direction to frame a code of conduct for Patent and Trademark Agents, MHC’s decision on prior arts, and the settlement between Dabur and Dhruv Rathee of their trademark and copyright dispute. Anything we are missing out on?
Here is the scoop: Background The Respondent, Novartis, owns a patent EP 2 959 894 for a specific use of fingolimod. They sought an Arrow declaration that the importation, disposal, use and keeping by them of generic fingolimod in the UK for that specific use would have been obvious at the priority date of the patent in question ([5]).
Here is our recap of last week’s top IP developments including summary of the posts on the Lenacapavir patentapplication and oppositions, ANRF and corporatisation of research, the copyright dispute between Jasleen Royal and T Series, and DHC’s recent order in Master Arnesh Shaw v. Anything we are missing out on?
In this guest post, Prathibha Sivasubramanian and Sreenath Namboodiri discuss the combined effect of these changes on transparency, the public information system in the Indian patent regime, and public health. Other International Developments Illinois District Jury finds that AWS infringed Kove’s data storage patents.
Just like other patents, the patent protection on Blockchain also achieves exclusive rights to its inventor or assignee in exchange of details about the blockchain invented to be released in the public domain. In recent times, globally more and more patentapplications are being filed for blockchain technology.
Just like other patents, the patent protection on Blockchain also achieves exclusive rights to its inventor or assignee in exchange of details about the blockchain invented to be released in the public domain. In recent times, globally more and more patentapplications are being filed for blockchain technology.
Just like other patents, the patent protection on Blockchain also achieves exclusive rights to its inventor or assignee in exchange of details about the blockchain invented to be released in the public domain. In recent times, globally more and more patentapplications are being filed for blockchain technology.
Cloudbreak Therapeutics, LLC , provides some interesting insights into patent challenge strategies, and their consequences, when a potentially infringing product is not yet on the market. Allgenesis lost at the Patent Trial and Appeal Board (PTAB), which issued a final written decision upholding the patentability of the challenged claims.
created a “patent thicket” around HUMIRA to block biosimilars from entering the market and entered into “reverse payment” settlement agreements with biosimilar applicants to further delay entry. ” On top of that, the panel noted, many of the patents at issue had survived inter partes review. .”
Huawei and Verizon settle their FRAND patent dispute concerning the infringement claims in Texas, which was done shortly after the start of the trial. Through the settlementwhich was under confidential terms, the parties settle their patent dispute and lawsuits. Image Source: gettyimages]. Chinese market.
Other Posts Timelines under Rule 138 of Patent Rules are to be interpreted strictly and there cannot be any leeway under Rule 49.6 of PCT Regulations, says Delhi High Court The DHC ruled that timelines for filing national phase applications cannot be extended, in light of India’s reservation to the PCT Regulations on this.
Cloudbreak Therapeutics, LLC addresses whether an IPR petitioner can assert Article III standing on appeal based on potential infringement liability and potential preclusive effects on its patents. 10,149,820 (the “’820 patent”), which is directed to compositions and methods for treating pterygium.
Introduction Patent trolls are entities that do not actively develop their inventions but instead acquire patent rights for obvious inventions to prevent others from working on them or to collect licensing fees. Large firms sometimes monopolize obvious inventions, and in such cases, patent trolls can help small businesses fight back.
Last week we published 9 posts on topics such as our comments on the proposed Trademarks (1st Amendment) Rules, the Madras High Court’s decision with respect to patentability of business methods, and Union Minister of State for Commerce’s response on ability of the current IPR regime to cater concerns arising out of AI generated work.
Together, they collectively replace inter partes reexamination, with post-grant review being available immediately after patent issuance, and inter partes review becoming available only after the period for post-grant review has passed. Final Rules for Trials before the Patent Trial and Appeal Board.
Highlights of the Week Hot-Tubbing in Indian IP Litigation: Delhi High Court Issues Directives in High-Stakes Patent Infringement Case Image from [link] here Recently, the DHC issued directives regarding expert evidence in the Perjeta patent litigation. The Patent Act: Catch 22 Does the Patent Act prevail over the Competition Act?
I brought experience as a contributor to DTSA (my research and reform proposal was the basis for DTSA’s whistleblower immunity provision), lead author of a widely adopted intellectual property casebook, lead author of the Patent Case Management Judicial Guide (PCMJG), and organizer of over 60 IP education programs for federal judges since 1998.
The various forms of intellectual property are already well known- trademarks, patents, copyrights, industrial designs, trade secrets, domain names and geographical indications. Things to Keep in Mind Maintaining Secrecy – Only inventions and designs which are not previously disclosed can be registered for patents and industrial designs.
Here is our recap of last week’s top IP developments including summaries of posts on the new Patent (Amendment) Rules, and some thoughts on safeguards which can be used by intermediaries to prevent trademark infringement. Some Concerns about the Amendment Process to Key Patent Levers: A “Captured” Patent Office?
They requested that access to this information be limited and excluded, in particular, access by Fujifilm's R&D staff, sales staff and staff involved in prosecution of patentapplications in the next 5 years. They also requested that the number of people with access be limited to 3 staff members.
The Controller on working examples is surely going to interest patent lawyers. Remanding the matter back to the Patent Office, the Court clarified that a working example does not define the patent’s scope. Controller of Patents on May 14, 2024 (Delhi High Court) A patentapplication for a formulation of probiotic was rejected.
on 3 January, 2024 (Madras High Court) In this case, the fourth respondent had filed a patentapplication for “fluorescence based imaging and monitoring” in the Indian Patent Office, Delhi. This jurisdiction will be irrespective of the location of the “appropriate patent office”. London Pride” trademark dispute.
Government Must Face Patent Case Over Armored Vehicles (Source: Reuters). Blake Brittain: Biden’s PTO Pick Calls for Clarity on Patent-Eligibility Controversy (Source: Reuters). Manoj Kumar: India to Push for Patent Waiver for COVID-19 Vaccines at WTO (Source: Financial Post). New Job Postings on Patently-O: McNeill Baur.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content